Compartir
Título
Effect of implementing the European guidelines for functional evaluation before lung resection on cardiorespiratory morbidity and 30-day mortality in lung cancer patients: a case-control study on a matched series of patients
Autor(es)
Palabras clave
Clinical guideline
Surgical risk evaluation
Postoperative mortality
Postoperative cardiorespiratory morbidity
Clasificación UNESCO
3213 Cirugía
3201.01 Oncología
Fecha de publicación
2014
Editor
Oxford University Press
Citación
Novoa, N., Jimenez, M. F., Aranda, J. L., Rodriguez, M., Ramos, J., Gomez Hernandez, M. T., y Varela, G. (2014). Effect of implementing the European guidelines for functional evaluation before lung resection on cardiorespiratory morbidity and 30-day mortality in lung cancer patients: A case-control study on a matched series of patients. European Journal of Cardio-Thoracic Surgery, 45(4), e89-e93. https://doi.org/10.1093/ejcts/ezt596
Resumen
[EN] OBJECTIVES: We hypothesized that postoperative cardiorespiratory morbidity and/or 30-day death rates decreased after implementing
the new European ERS/ESTS guidelines for functional evaluation before lung resection and tested the hypothesis by means of a case–
control study.
METHODS: The analysis included a series of 916 consecutive patients who underwent an anatomical pulmonary resection for non-smallcell
lung cancer in our centre. Patients were divided into cases (September 2009–August 2012) and controls (December 2002–August
2009). We reviewed the records from a prospective computerized database; the final dataset included no missing data. The primary
studied outcomes were the occurrence of cardiorespiratory morbidity or 30-day death after surgery. The patients were 1:1 propensity
score matched according to the following variables age, ppoFEV1% and the need of pneumonectomy.
RESULTS: After the matching process, 670 cases (335 cases and 335 controls) entered into the study. The rates of pneumonectomy in cases
and controls were 5.7 and 13.2%, respectively, (P < 0.0001) in the whole series and 5.7 and 6.9% after matching (P = 0.52). Cardiorespiratory
morbidity was 8.1% (27 of 308) in cases and 9.8% (33 of 335) in controls [odds ratio (OR): 0.8; 95% confidence interval (CI): 0.4–1.4]. Thirtyday
mortality was 0.90% (3/335) in cases and 1, 2% (4 of 335) in controls (OR: 0.7; 95% CI: 0.1–4.4).
CONCLUSIONS: Although we have observed a trend towards lower cardiorespiratory morbidity and 30-day mortality after implementing
ERS/ESTS guidelines, the benefit of the guidelines remains unclear. Multicentric analysis including a very large number of cases is needed
to demonstrate statistically the effectiveness of the guidelines to reduce operative mortality and cardiorespiratory morbidity. Maybe the
effect could be easier demonstrated in series with higher operative mortality or morbidity
URI
ISSN
1010-7940
DOI
10.1093/ejcts/ezt596
Versión del editor
Aparece en las colecciones













